Related Experiment Videos
Renal dopamine synthesis from precursors
M Barthelmebs1, B Vailly, J Velly
1Institut de Pharmacologie, URA D0589 CNRS, Faculté de Médecine, Université Louis Pasteur, Strasbourg, France.
American Journal of Hypertension
|June 1, 1990
Summary
Levodopa (L-dopa) acts as a kidney-specific prodrug, significantly increasing urinary dopamine excretion without systemic effects. This suggests L-dopa
Area of Science:
- Pharmacology
- Nephrology
- Neuroscience
Background:
- Dopamine (DA) plays a crucial role in regulating renal function.
- Levodopa (L-dopa) is a precursor to dopamine, commonly used for Parkinson's disease.
- The potential of L-dopa as a kidney-directed prodrug is not fully understood.
Purpose of the Study:
- To investigate L-dopa's characteristics as a kidney-directed dopamine prodrug.
- To examine the effects of L-dopa on renal function and dopamine synthesis in vivo and in vitro.
- To determine the role of endorenal dopamine synthesis and DA-1 receptor stimulation in L-dopa's renal effects.
Main Methods:
- Administered L-dopa subcutaneously to Wistar rats and measured urinary dopamine excretion.
- Assessed systemic effects on blood pressure and heart rate.
- In anesthetized rats, evaluated L-dopa's impact on natriuresis, diuresis, and renal blood flow, using carbidopa and SCH 23390 as inhibitors.
- Utilized isolated perfused rat kidneys to compare dopamine synthesis from L-dopa and gludopa.
- Investigated L-dopa metabolism in nonfiltering kidneys with restricted dopa decarboxylase access.
Main Results:
- Subcutaneous L-dopa administration resulted in a 450-fold increase in 24-hour urinary dopamine excretion without affecting systemic blood pressure or heart rate.
- In vivo, L-dopa enhanced natriuresis, diuresis, and renal blood flow, effects abolished by carbidopa and SCH 23390, indicating dependence on endorenal dopamine synthesis and DA-1 receptor activation.
- In isolated perfused kidneys, L-dopa yielded more dopamine than gludopa, and its metabolism was not hindered by restricted access to dopa decarboxylase on the basolateral membrane.
Conclusions:
- L-dopa functions as a kidney-directed dopamine prodrug, increasing renal dopamine levels without systemic side effects.
- The observed renal effects of L-dopa are mediated by endogenously synthesized dopamine acting on DA-1 receptors.
- L-dopa demonstrates efficient renal synthesis of dopamine, outperforming gludopa, particularly under conditions limiting enzyme access.